We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Brain Imaging and Pain in Irritable Bowel Syndrome

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00065754
First Posted: August 1, 2003
Last Update Posted: September 20, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
National Center for Complementary and Integrative Health (NCCIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by (Responsible Party):
University of Florida
July 31, 2003
August 1, 2003
September 20, 2011
September 2003
December 2007   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00065754 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Brain Imaging and Pain in Irritable Bowel Syndrome
Brain Imaging and Pain: Analysis of Placebo Analgesia
This study examines the mechanisms, including brain imaging of placebo analgesia
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Double
Irritable Bowel Syndrome
Drug: placebo
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
50
December 2007
December 2007   (Final data collection date for primary outcome measure)

Inclusion criteria:

  • Irritable Bowel Syndrome
  • English speaking

Exclusion criteria:

  • Chronic pain condition other than Irritable Bowel Syndrome
  • Medical condition that would contraindicate use of lidocaine
  • Clinical criteria for fibromyalgia
  • Presence of systemic disease such as diabetes, thyroid, gastrointestinal or liver disease, collagen vascular disease, malignancy, focal or neurological
  • Seropositive HIV
  • Pregnancy
Sexes Eligible for Study: All
18 Years to 70 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00065754
R01AT001424-01( U.S. NIH Grant/Contract )
R01AT001424-01 ( U.S. NIH Grant/Contract )
No
Not Provided
Not Provided
University of Florida
University of Florida
  • National Center for Complementary and Integrative Health (NCCIH)
  • National Institute of Neurological Disorders and Stroke (NINDS)
Principal Investigator: Michael E Robinson, PhD University of Florida
University of Florida
August 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP